ICON Public Limited Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICLR research report →
About the company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization.
- CEO
- Barry Balfe
- IPO
- 1998
- Employees
- 40,950
- HQ
- Dublin, IE
Price Chart
- Market Cap
- $13.25B
- P/E
- 30.57
- P/S
- 1.61
- P/B
- 1.42
- EV/EBITDA
- 12.83
- Div Yield
- 0.00%
- Gross Margin
- 24.08%
- Op Margin
- 10.39%
- Net Margin
- 5.35%
- ROE
- 4.70%
- ROIC
- 5.63%
- Revenue
- $8.25B · -0.37%
- Net Income
- $229.34M · -71.02%
- EPS
- $2.92 · -69.58%
- Op Income
- $1.01B
- FCF YoY
- -22.94%
- 52W High
- $211.00
- 52W Low
- $66.57
- 50D MA
- $133.42
- 200D MA
- $149.23
- Beta
- 1.27
- Avg Volume
- 1.21M
Get TickerSpark's AI analysis on ICLR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 1, 26 | Egan Kevin Francis | other | 0 |
| Jun 1, 26 | Elliott Jeffrey Thomas | other | 0 |
| May 14, 26 | Murphy Ronan Martin | other | 5,005 |
| May 14, 26 | Murphy Ronan Martin | sell | 5,005 |
| May 14, 26 | CLIMAX JOHN DR | other | 5,005 |
| May 14, 26 | CLIMAX JOHN DR | sell | 5,005 |
| May 14, 26 | McCague Eugene Pacelli | other | 3,255 |
| May 14, 26 | McCague Eugene Pacelli | sell | 3,255 |
| Mar 18, 26 | Balfe Barry Edward | other | 0 |
| Mar 18, 26 | Balfe Barry Edward | other | 886 |
Our ICLR coverage
Recent articles, reports, and earnings notes.
No research on ICLR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ICLR report →Similar companies
Peers in the same neighborhood.